Brain Development Measured With MRI in Children With Down Syndrome Correlates With Blood Biochemical Biomarkers - 27/02/19

Abstract |
Background |
Down syndrome (DS) is a neurodegenerative disease with unknown mechanisms. β-Amyloid peptide (Aβ) and tau protein (Tau) are known to play a role, while vitamin A (VA) has an effect on normal neurological function. In a case-control study, we quantitatively evaluated whole brain and hippocampal volumes of DS children and analyzed the correlation of hippocampal volumes with blood levels of Aβ, Tau and VA.
Methods |
All subjects underwent magnetic resonance imaging (MRI) of the brain. The whole brain and hippocampal volumes were quantitatively analyzed using voxel-based morphometry (VBM) and stereology respectively. The blood levels of Aβ, Tau, and VA were detected by enzyme-linked immunosorbent assay and high-performance liquid chromatography, respectively.
Results |
Thirty DS children and twenty healthy controls were recruited. Whole brain and hippocampal volumes were significantly smaller in individuals with DS than in healthy controls. In both groups, whole brain and hippocampal volumes increased in accordance with age. The results of correlation analysis suggested that Aβ42/Aβ40 and VA are associated with hippocampal volume in DS patients.
Conclusion |
DS children exhibited neurodevelopmental defects, even at an early age. Aβ42/Aβ40 and VA may affect hippocampal volume in DS patients.
Le texte complet de cet article est disponible en PDF.Keywords : Down syndrome, Neurodegenerative disease, β-amyloid peptide, Vitamin A
Plan
| Funding: This research was supported by National Natural Science Foundation of China (81600690), Jin Lei Pediatric Endocrinology Growth Research Fund for Young Physicians (PEGRF201607008). |
|
| Disclosure: The authors declare that they have no conflict of interest. |
Vol 92
P. 43-47 - mars 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
